AliveDx Suisse S.A. and Ozgun Kimya A.S. have signed a distribution agreement, which will enable Ozgun Kimya A.S. to distribute the MosaiQ® solution in Türkiye. The distribution agreement takes effect immediately.
This strategic partnership reaffirms AliveDx’s consistent commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry and enhance patient care in Türkiye.
“Our partnership with Ozgun Kimya A.S. enables us to demonstrate our commitment to transforming patient care on a global scale. We look forward to partnering with Ozgun Kimya A.S. and supporting the Turkish healthcare system with our fast and innovative disease detection solutions,” said Manuel O. Méndez, CEO of AliveDx.
Ozgun Kimya A.S. is a healthcare company that is dedicated to offering modern diagnostic solutions in the health and life sciences fields. Founded in 1990 by Kursat Ozgun, Chairman of the Board of Directors, Ozgun Kimya A.S. represents world-renowned and reliable brands in the fields of IVD Diagnostics, Molecular Biology – Genetics, Apheresis and Automation. It offers 24/7 expert sales and after-sales support services.
“We are thrilled to collaborate with AliveDx. The innovative MosaiQ microarray multiplexing diagnostic solutions will bolster our offering even further. This will allow us to provide the Turkish healthcare industry with the newest, most cutting-edge technologies designed to enhance patient lives,” said Kursat Ozgun, CEO of Ozgun Kimya A.S.
To learn more, please visit the Ozgun Kimya A.S. website.
Would you like to know more about our MosaiQ solution? Click here:
